Skip to main content

SHRX · Sharp Therapeutics Corp. · Financials

1.37 CAD +0.00 (+0.00%) At close · Sep 21 Intraday price with Plus
Market Cap
41.20M CAD
Shares
30.08M
Volume · Sep 21 200 Avg daily vol (3 sessions) 1433

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Net Income
-$6.17M -89.4%
FY2025 Net Income FY2024–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024
-$5.51M -$2.54M
-$6.17M -$3.26M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.